{
  "report_rows": [
    {
      "kpi": "Q2 2026 adjusted EPS",
      "prediction": "IN-LINE",
      "answer": "pred ~$2.49 vs. cons $2.47",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 2026 net sales",
      "prediction": "IN-LINE",
      "answer": "pred ~$2.29B vs. cons $2.30B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 2026 organic sales growth",
      "prediction": "MISS",
      "answer": "pred ~0.7% vs. cons 1.0%",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Q3 2026 adjusted EPS",
      "prediction": "LOWER",
      "answer": "guide ~$2.49 vs. cons $2.51 (Q3 2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY2026 adjusted EPS",
      "prediction": "LOWER",
      "answer": "guide ~$9.95 vs. cons $10.00 (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q3 2026 organic sales growth",
      "prediction": "LOWER",
      "answer": "guide ~1.8% vs. cons 2.3% (Q3 2026)",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": -3.2,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -4.5,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "A near-consensus EPS result is likely to be outweighed by weaker organic growth and modestly lower Q3/FY2026 earnings implications; the out-period math should drive downward estimate revisions after the initial reaction.",
  "day5_confidence": "MEDIUM"
}